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Abstract
Background: The prevalence and predictors of functional status and disability of elderly people have been studied
in several European countries including Spain. However, there has been no population-based study incorporating
the International Classification of Functioning, Disability and Health (ICF) framework as the basis for assessing
disability. The present study reports prevalence rates for mild, moderate, and severe/extreme disability by the
domains of activities and participation of the ICF.
Methods: Nine populations surveyed in previous prevalence studies contributed probabilistic and geographically defined
samples in June 2005. The study sample was composed of 503 subjects aged ≥75 years. We implemented a two-phase
screening design using the MMSE and the World Health Organization-Disability Assessment Schedule 2
nd edition (WHO-
DAS II, 12 items) as cognitive and disability screening tools, respectively. Participants scoring within the positive range of
the disability screening were administered the full WHO-DAS II (36 items; score range: 0-100) assessing the following
areas: Understanding and communication, Getting along with people, Life activities, Getting around, Participation in
society, and Self-care. Each disability area assessed by WHO-DAS II (36 items) was reported according to the ICF severity
ranges (No problem, 0-4; Mild disability, 5-24; Moderate disability, 25-49; Severe/Extreme disability, 50-100).
Results: The age-adjusted disability prevalence figures were: 39.17 ± 2.18%, 15.31 ± 1.61%, and 10.14 ± 1.35% for
mild, moderate, and severe/extreme disability, respectively. Severe and extreme disability prevalence in mobility
and life activities was three times higher than the average, and highest among women. Sex variations were
minimal, although life activities for women of 85 years and over had more severe/extreme disability as compared
to men (OR = 5.15 95% CI 3.19-8.32).
Conclusions: Disability is highly prevalent among the Spanish elderly. Sex- and age-specific variations of disability
are associated with particular disability domains.
Background
The increasing survival rate from chronic diseases and
decreasing birth rate are making Spain one of the fastest
ageing societies in the world [1,2]. The proportion of the
population over 65 years of age doubled during the last
30 years and is expected to double again by 2050 [3].
The 1999 National Survey on Disability, Impairments and
Health indicated that 59% of individuals with disabilities
in Spain were aged over 65 years. Moreover, 33% of
those over 65 were disabled as identified in this survey
[4]. Disability among the elderly people represents a
major public health concern in Spain. National preva-
lence rates of disability and a quantitative approach to
disability determinants are needed for service develop-
ment and evidence-based health decision-making with
regard to this population.
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variety of approaches to disability measurement. These
varied strategies have hampered comparability across
studies and have rendered highly variable epidemiologi-
cal conclusions on the distribution of disability [5]. Pre-
vious enquiries have frequently focused on dependence
for activities of daily living (ADL, e.g., eating, moving
around the home; cf., Katz index, Barthel index), and
sensory and cognitive functions [4,6]. By contrast, the
International Classification of Functioning, Disability
and Health (ICF) [7] incorporates a multifactorial
approach to disability with two core components: limita-
tions in activities and participation, and changes in body
structure and functions. Under the ICF model diseases,
environmental factors, and personal characteristics can
all function as determinants of disability. According to
this framework, an individual’s functional status results
from the interaction between the health problems and
the physical, social, and psychological context of the
individual.
The ICF provides the basis to develop disease-specific
disability profiles [8]. Moreover, the ICF facilitates the
identification of targets in rehabilitation, assessment of
intervention outcomes, and social and health service
planning [9]. For instance, ICF-based models of assess-
ment, as the World Health Organization Disability
Assessment Schedule 2
nd Edition for epidemiological use
(WHO DAS-II) [10], pinpoint specific spheres of the
individuals personal and social functioning, which may be
linked to specific needs of social support. Along these
lines the ICF checklist for clinical use [11] provides a
multi-faceted classification of the components of disabil-
ity, the impact of environmental aids and the composi-
tion of the package of services that may best suit the
needs of a particular individual.
The ICF scheme opens up the possibility of cross-
national and multi-dimensional assessment of disability,
thereby offering a more extensive picture of which aspect
may be affected for any given individual or cohort. The
WHO-DAS II has been developed under the ICF scheme
and may constitute an effective tool for epidemiological
surveys. WHO-DAS II is well suited for prevalence stu-
dies implementing door-to-door designs given that both
the screening (12 items) and the full (36 items) versions
of this instrument are available [12,13]. Traditional
approaches to disability assessment incorporate items
relevant to disability, particularly for clinical use in nur-
sing (e.g., Katz index, Barthel index). However, they fre-
quently amalgam items on function (e.g., digestive and
urinary function, sphincter control, motor function)
without any indication of impact on social functioning.
By contrast, WHO-DAS II provides a systematic
approach to various social and functional domains of dis-
ability, which are assessed separately over a single
5-point Likert scale. As an additional advantage, WHO-
DAS II has been designed specifically for epidemiological
use being available in various languages and formats [14].
There have been no previous population-based studies
on health and functioning in the Spanish elderly popula-
tion under the ICF framework. The ICF system may
provide a more comprehensive framework to disability
witch could potentially become a standard for psycholo-
gical assessment [15].
The goal of the present study was to obtain prevalence
estimates of disability levels in a Spanish elderly popula-
tion using WHO-DAS II (12 items) as a screening tool,
WHO-DAS II (36 items) as the basis for a multi-faceted
assessment of disability, and ICF disability severity
ranges to define cases of mild, moderate, and severe/
extreme disability.
Methods
Study population
Participants were part of a recent Spanish epidemiologi-
cal multi-population study composed of nine probabilis-
tic and geographically defined samples conducted in
June 2005 in Spain (Figure 1). Co-investigators in charge
of recruitment in each location were asked to contribute
an average of 60 participants aged 75 years of more.
Details on the characteristics of the resulting sample
including its geographical distribution are available in
Virues-Ortega et al. [16].
Sampling procedure
We conducted a power analysis for cross-sectional
designs [17]. The expected prevalence used during power
analysis was that of individuals 70 years of age or more
reported by de Pedro-Cuesta [18] (i.e., 707/12,232). Preci-
sion was set to 2%. Power analysis indicated that a sample
size of 523 or more participants was required.
We requested from the principal investigators of the ori-
ginal surveys a census-based random sample of individuals
aged 75 years or more from the population originally sur-
veyed in their respective prevalence studies. Sampling
ended when an average of 60 participants per group was
reached. We used nationwide age- and sex-specific mor-
tality rates for the birth cohorts under study in order to
estimate the number of participants to be sampled for
each location [19]. Mortality was proportional to the delay
from the original survey and so were the number of parti-
cipants to be sampled. Groups used their original census-
based sampling procedure to avoid selection bias. In
locations with very limited number of survivors a new geo-
graphically-defined sample was obtain from selected city
neighbourhoods. This approach ensured that the main
attributes of all sub-samples in terms of environment, liv-
ing arrangements and residential status were represented.
Cohorts included individuals living in their homes and
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and urban areas. Losses resulted from dead and inability
to locate individuals surveyed in earlier studies, circum-
stances unlikely to induce specific selection biases in a
geographically-defined prevalent sample. Death excludes
individuals from the pool of survivors. Non-located indivi-
duals (due to death or change of residence outside the
geographic residence) shall also be considered outside the
sampling frame.
Study design
The screening phase comprised the administration of
WHO-DAS II (12 items) to all eligible participants. This
i n s t r u m e n tw a su s e da st h eb a s i sf o rs c r e e n i n gp a r t i c i -
pants before further disability assessments were con-
ducted. This instrument has been recently validated with
the Spanish population showing optimal internal
consistency (Cronbach alpha = 0.89) [20]. Direct scores
range from 0 to 48, with higher scores indicating greater
disability. Given that the predictive value of specific
WHO-DAS II (12 items) cut-off points has not been
established for this population, all participants scoring
above 0 passed on to the assessment phase in which the
full 36-item version of WHO-DAS II was administered.
In view of the fact that dementia is the primary health
condition contributing to disability in the elderly [20] and
that it is highly under-diagnosed in Spain [21], a simulta-
neous cognitive screening procedure was conducted. As
indicated by Pressley et al. [22], a multi-source approach
may maximize the detection of dementia and therefore be
an optimal strategy for studying the prevalence and deter-
minants of dementia and disability. The Spanish version of
the Mini-Mental State Examination (MMSE) [23,24] was
used for screening purposes (with a cut-off of 24). Further
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Figure 1 Locations participating in the study. 1. El Prat de Llobregat (Barcelona), n = 59; 2. Irún-Hondarribia (Guipúzcoa), n = 57; 3. Zaragoza,
n = 31; 4. Gerona, n = 75; 5. Isla de Arosa (Pontevedra), n = 53; 6. Getafe (Madrid), n = 98; 7. Santiago de Compostela (La Coruña - Corunna),
n = 33; 8. Cantalejo (Segovia), n = 24; 9. Toledo, n = 73.
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design are available elsewhere [16].
The study was approved by the Carlos III Health Insti-
tute Human Subjects Review Board (ref. no. CEI PI
4_2009), and written informed consent was given by all
participants in accordance with the Helsinki Declaration.
Participants were visited twice at their homes or nursing
homes. During the first visit, cognitive screening
through the Spanish version of the MMSE was adminis-
tered [16]. In addition, health status was determined
through direct medical examination and a structured
medical questionnaire. Interviewers had access to parti-
cipants’ hospital and primary care medical records.
A physician specialized or undergoing specialized train-
ing in neurology, psychiatry, or geriatrics conducted this
first visit. On the second visit, a psychologist, physician
or nurse evaluated the participant’s functioning and dis-
ability. Interviewers underwent formal training in all
assessment procedures used during the study.
Disability assessment (WHO-DAS II)
WHO-DAS II (36-item) is a self-reported scale covering
six disability domains assessed over the 30-day period pre-
ceding administration [25]: Understanding and communi-
cation (UAC); Getting around (GAR); Self-care (SCA);
Getting along with people (GAP); Life activities (LAC);
and Participation in society (PSO) (see definitions in Table
1). Items are answered in a 5-point Likert format (1: none;
5: extreme), which grades the difficulty experienced by the
participant in performing a given activity. The preliminary
scoring rules developed by the WHO were used as
provided by the WHO Spanish Official Group (Dr. Vaz-
quez-Barquero, Universidad de Cantabria, personal com-
munication). We obtained summary-index and domain
scores by summing across items and transposing the result
to a 100-point scale. Items D5.5 thru D5.8 (work) were
omitted in all subjects, as most individuals in our sample
were not gainfully employed. Similarly, items D5.2-D5.5
(life activities) were not applicable in a sub-sample of 37
positively screened participants, as they had no household
activities assigned. In addition, item D4.5 (sexuality) was
also excluded, owing to an unusually high proportion of
missing values (47.2%). WHO-DAS II proxy informant
version was administered for participants who were unable
to answer questions due to cognitive or motor disabilities.
WHO-DAS II subscales and summary indices were coded
using the ICF disability categories; namely: No problem
(0%-4%); Mild problem (5%-24%); Moderate problem
(25%-49%); Severe problem (50%-95%); and Extreme pro-
blem (95%-100%) (see definitions in Table 1).
Data analysis
Cases of mild, moderate, and severe/extreme disability
were identified to obtain age- and sex-specific disability
prevalence and standard errors, according to WHO-
DAS II domains and summary index. Standard errors
were calculated from the binomial distribution where
the product of the proportion multiplied by N was
below 5 [26]. In addition, we obtained age-standardized
prevalence figures according to the European standard
population weights (0.50, 0.25 and 0.25 for 75-79, 80-84
and ≥85 years of age, respectively [27]). Direct preva-
lence adjustments are used to compensate the disparity
in the age structure across genders between the popula-
tion and the sample under study. Finally, we used the
sex and age distribution for those aged 75 years and
over in the Spanish population to estimate the number
of individuals with severe/extreme disability in the
Table 1 Qualitative definition of WHO-DAS II subscales
and ICF disability levels
WHO-DAS II
Subscales
Definition
a
UAC (6, 0.81)
b Difficulty concentrating on something for more
than 10 min and learning new tasks.
GAR (5, 0.88) Difficulty standing for long periods, moving
around the house and getting out of the house.
SCA (4, 0.71) Difficulty in bathing, getting dressed, feeding and
being independent while being alone.
GAP (5, 0.77) Difficulty in social activities such as starting and
maintaining a conversation, dealing with unknown
people and maintaining or making new friends.
LAC (4. 0.96) Difficulty in performing instrumental activities
quickly and effectively, particularly household
duties.
PSO (8, 0.95) Difficulty joining community activities such as
festivities or religious. Lack of self-confidence due
to health problems.
Summary Index (32,
0.93)
Average score across the six domains.
ICF Disability levels Definition
c
No problem (0-4%) No problem as measured by standardised
instruments (5% error allowed).
Mild disability
(5-24%)
Problem that expands up to a fourth of the time
or, alternatively, the first fourth of the score range
of a standardised instrument on self-reported
difficulty for an activity/participation.
Moderate disability
(25-49%)
Problem that expands up to a half of the time or,
alternatively, half of the score range of a
standardised instrument on self-reported difficulty
for an activity/participation.
Severe disability
(50-95%)
Problem that expands up to 95% of the time or,
alternatively, a score on a standardised instrument
on self-reported difficulty for an activity/
participation up to 95% of the score range.
Extreme disability
(96-100%)
Complete problem as measured by standardised
instruments; 5% error allowed.
UAC = Understanding and communication; GAP = Getting along with people;
LAC = Life activities; GAR = Getting around; PSO = Participation in society;
SCA = Self-care. Activity = execution of a task or action by an individual;
Participation = involvement in a life situation; Problem: self-reported difficulty/
number of days with disability over the last month in the actual performance
or the abstract capacity (no environmental aids) complete an activity.
aAccording to Vázquez-Barquero et al. 2006, p. 88.
bNumber of items,
Cronbach’s a.
cAccording to WHO, 2001, p. 134.
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of age for 2009: 3,846,132 inhabitants; source: http://
www.ine.es). Binary logistic regression was used to
obtain odds ratios (OR) and 95% confidence intervals
(95% CI) in order to compare risk for disability status
across genders, age groups, and disability domains.
Results
The final sample comprised 546 participants of which
440 were positive to the disability screening and 106
scored 0 in WHO DAS II (12 items). Of this total, 503
had complete datasets (mean age: 82.0, SD: 4.8; 62.6%
women). Most participants were of rural-mixed, urban,
and sub-urban origin, mid or mid-low social class, and
had a low level of education. Two-thirds of the sample
was living in rural areas (municipality size ≤ 10000 inha-
bitants). The actual proportion in the whole country is
slightly inferior (≈60%; source: Spanish National Insti-
tute of Statistics, http://www.ine.es/censo_accesible/es/
seleccion_colectivo.jsp?fType=1), which may have bias
slightly our results in terms of disability. The socio-
demographic characteristics of the study population are
shown in Table 2. Prevalent health conditions and
morbidity of study sample is described in detail on
Table S1 (online additional file 1).
Figure 2 shows a flow chart portraying the sample
attrition. A total of 503 computable datasets were
available. Non-computable scores were due to incom-
plete information and lack of collaboration during the
second visit (n = 43). A total of 49 participants had
dementia; among them only one score 0 on the disabil-
ity screening. Seven out of 48 dementia cases scoring
within the positive range of the disability screening did
not have computable scores at the WHO-DAS II
(36 items).
Disability prevalence
Age-standardized prevalence figures are presented in
Figure 3 (see age- and sex-specific prevalence of disabil-
ity in Table 3). Table 4 present binary logistic models of
the various disability domains across age intervals and
gender taking individuals with severe/extreme disability
as cases. Due to the limited number of individuals scor-
ing within the range of extreme disability, severe and
extreme disability categories were collapsed into a
severe/extreme disability category. Total age-standar-
dized prevalence rates for disability (age ≥75) based on
the WHO-DAS II summary index was: 39.17 ± 2.18%
(mild disability); 15.31 ± 1.61% (moderate disability);
and 10.14 ± 1.35% (severe/extreme disability).
Prevalence varied acrossW H O - D A SI Id i s a b i l i t y
domains, sex and age (Table 3). Disability across age in
each domain was higher among women (mild: 40.32 ±
2.76% vs. 37.23 ± 3.53%; moderate: 18.41 ± 2.18% vs. 10.11
± 2.20%; severe/extreme: 11.75 ± 1.81% vs. 7.45 ± 1.91%).
Both sexes scored similarly in UAC, with a higher preva-
lence of mild disability plus a higher prevalence of severe/
extreme disability for individuals aged 85 years and over as
compared to younger age groups (21.33 ± 3.34%, OR =
4.71, 95% CI = 2.29-9.70). Insofar as GAR was concerned,
there was a noticeable difference between men and
women, with a higher prevalence of mild disability among
men across all age groups (34.57 ± 3.47% vs. 24.13 ±
2.41%, OR = 2.56, 95% CI 1.75-2.56) and a high prevalence
of severe/extreme disability among women aged 85 years
and over (51.25 ± 4.47% vs. 20.00 ± 5.96%, OR = 3.71, 95%
CI 2.03-6.76). There was a high prevalence of no-problem
and mild disability in SCA (58.45 ± 2.20%; 23.46 ± 1.89%),
particularly among men (OR = 1.61, 95% CI 0.99-2.63).
However, prevalence of disability was higher among the
oldest women, while men of the same age group displayed
a higher proportion of SCA disability-free individuals
(51.11 ± 7.45% vs. 35.24 ± 4.66%, OR = 1.92, 95% CI 0.94-
1.92). The highest proportion of disability-free individuals
was found for the GAP domain (77.14 ± 1.87%), with no
age- or sex-specific pattern. In contrast, the LAC domain
showed the highest prevalence of severe/extreme disability
Table 2 Characteristics of study participants (n = 503)
% (n)
Age (years)
75 - 79
Women 24.85 (125)
Men 15.31 (77)
80 - 84
Women 16.90 (85)
Men 13.12 (66)
≥ 85
Women 20.87 (105)
Men 8.95 (45)
Self-reported social status
Low 10.14 (51)
Middle-low 30.42 (153)
Middle 51.29 (258)
Middle-high 6.96 (35)
High 1.19 (6)
Education
Illiterate 9.74 (49)
Primary incomplete 41.55 (209)
Primary complete 34.19 (172)
Some secondary or higher 14.51 (73)
Municipality size
1 - 10,000 inhabitants 65.40 (329)
> 10,000 inhabitants 34.60 (174)
Cognitive status (MMSE score)
< 24 19.48 (98)
≥ 24 80.52 (405)
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women aged 85 years and over, as compared to men of
the same age (52.04 ± 5.05% vs. 28.95 ± 7.36%, OR = 5.15
95% CI 3.19-8.32). Prevalence of PSO disability was similar
for men and women, except for the prevalence of the dis-
ability-free category, which was highest in men of 75 to 79
(72.73 ± 5.09% vs. 57.60 ± 4.42%).
In summary, differences in disability prevalence between
the sexes seem to be limited to GAR (mobility) and SCA
(personal activities of daily living) with women demonstrat-
ing higher difficulties in both cases. Prevalence varied sig-
nificantly across disability domains. The GAR and LAC
disability areas concentrated the highest proportions of
individuals with moderate to extreme disability. Finally, the
number of individuals with severe/extreme disability based
on the sex and age distribution of Spanish population for
2009 (age ≥75) [3] was 390,000 (95% CI 338,000 - 442,000).
Discussion
This study is among the few population-based surveys
reporting disability prevalence assessed according to the
ICF framework [28,29]. Our results provide a novel view
of disability among the Spanish elderly population.
Based on WHO-DAS II assessment and ICF disability
categories, our study estimated the prevalence of mild,
moderate, and severe/extreme disability for those aged
75 years and above. Prevalence rates of severe/extreme
disability equalled 10.14%, which works out to a number
of 390,000 individuals older than 75 in Spain meeting
the case definition used in this study. While most parti-
cipants displayed some degree of disability (2 out of
every 3), the proportion of severely disabled individuals
was approximately one tenth of the study sample. These
figures are in line with prior studies conducted on Eur-
opean populations using various approaches to the
assessment of disability [6,30]. Given the mixed-rural
and urban sample in the present study, we should com-
ment on the impact of habitat on dementia. In a recent
re-analysis of studies on the prevalence of dementia in
Spain, suburban populations showed higher prevalence
of Alzheimer’s disease while vascular dementia was
higher among suburban populations. The pattern was
WHO-DAS II 12 
Score ≥ 1 
n = 440 
WHO-DAS II 36 
Computable 
n = 397 
Dementia, n = 41 
WHO-DAS II 36 
Non-computable 
n = 43 
Dementia, n = 7 
WHO-DAS II 12 
Score = 0 
n = 106 
Dementia, n = 1 
Subjects with complete dataset, n = 503 
Sampling frame 
Age ≥ 75 
N = 1,293 
Study sample 
June 1, 2005 
N = 546 
Not located = 216 
Dead = 312 
Non participants = 219 
Figure 2 Sample attrition.
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Figure 3 Raw and age-standardised (European standard) prevalence of disability levels according to ICF disability ranges established
through the scores of WHO-DAS II 36 items (n = 503). NP: No problem; Mild: Mild disability; Mod: Moderate disability; Se/Ex: Severe or
extreme disability.
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there is a paucity of evidence for rural populations [18].
The age-standardised prevalence of disability found in
our study was considerably higher than the one reported
b yt h e1 9 9 9N a t i o n a lD i s a b i l i t yS u r v e yf o rt h es a m ea g e
groups [3] (64% vs. 46% of persons aged ≥ 75 with some
disability). The fact that our study population was con-
sisted of samples from nine different locations may in part
be a protection against selection bias, although our study
sample cannot be considered representative of the coun-
try’s population. Moreover, it should be noted that partici-
pants were recruited from the Central-Northern half of
the country, which registers lower mortality from all
causes [31] and higher longevity and quality of life than
does Southern Spain [32]. It should be noted, however,
that the presence of dementia cases among participants
Table 3 Age- and sex-specific prevalence of disability levels (n = 503)
UAC GAR SCA GAP LAC PSO Summary index
% ± SE % ± SE % ± SE % ± SE % ± SE % ± SE n % ± SE
MILD
Both sexes
75-79 30.69 ± 3.25 31.19 ± 3.26 21.78 ± 2.90 8.42 ± 1.95 15.79 ± 2.65 20.30 ± 2.83 86 42.57 ± 3.48
80-84 28.48 ± 3.67 32.45 ± 3.81 19.21 ± 3.21 9.93 ± 2.43 11.43 ± 2.69 17.22 ± 3.07 62 41.06 ± 4.00
≥85 31.33 ± 3.79 19.33 ± 3.22 30.00 ± 3.74 10.67 ± 2.52 8.09 ± 2.34 19.33 ± 3.22 49 32.67 ± 3.83
Male
75-79 27.27 ± 5.08 31.17 ± 5.28 22.08 ± 4.73 6.49 ± 2.81 8.96 ± 3.49 16.88 ± 4.27 29 37.66 ± 5.52
80-84 28.79 ± 5.57 39.39 ± 6.01 18.18 ± 4.75 10.61 ± 3.79 8.77 ± 3.75 12.12 ± 4.02 24 36.36 ± 5.92
≥85 31.11 ± 6.90 33.33 ± 7.03 26.67 ± 6.59 13.33 ± 5.07 10.53 ± 4.98 17.78 ± 5.70 17 37.78 ± 7.23
Female
75-79 32.80 ± 4.20 31.20 ± 4.14 21.60 ± 3.68 9.60 ± 2.63 19.51 ± 3.57 22.40 ± 3.73 57 45.60 ± 4.45
80-84 28.24 ± 4.88 27.06 ± 4.82 20.00 ± 4.34 9.41 ± 3.17 13.25 ± 3.72 21.18 ± 4.43 38 44.71 ± 5.39
≥85 31.43 ± 4.53 13.33 ± 3.32 31.43 ± 4.53 9.52 ± 2.86 7.14 ± 2.60 20.00 ± 3.90 32 30.48 ± 4.49
MODERATE
Both sexes
75-79 16.34 ± 2.60 15.35 ± 2.54 5.94 ± 1.66 3.47 ± 1.29 19.47 ± 2.87 11.39 ± 2.23 20 9.90 ± 2.10
80-84 21.19 ± 3.33 22.52 ± 3.40 8.61 ± 2.28 7.28 ± 2.11 19.29 ± 3.33 15.89 ± 2.98 21 13.91 ± 2.82
≥85 15.33 ± 2.94 24.67 ± 3.52 12.67 ± 2.72 7.33 ± 2.13 13.24 ± 2.91 25.33 ± 3.55 36 24.00 ± 3.49
Male
75-79 15.58 ± 4.13 11.69 ± 3.66 3.90 ± 2.21 3.90 ± 2.21 14.93 ± 4.35 6.49 ± 2.81 5 6.49 ± 2.81
80-84 18.18 ± 4.75 13.64 ± 4.22 4.55 ± 2.56 4.55 ± 2.56 21.05 ± 5.40 13.64 ± 4.22 7 10.61 ± 3.79
≥85 13.33 ± 5.07 17.78 ± 5.70 6.67 ± 3.72 6.67 ± 3.72 5.26 ± 3.62 17.78 ± 5.70 7 15.56 ± 5.40
Female
75-79 16.80 ± 3.34 17.60 ± 3.41 7.20 ± 2.31 3.20 ± 1.57 21.95 ± 3.73 14.40 ± 3.14 15 12.00 ± 2.91
80-84 23.53 ± 4.60 29.41 ± 4.94 11.76 ± 3.49 9.41 ± 3.17 18.07 ± 4.22 17.65 ± 4.13 14 16.47 ± 4.02
≥85 16.19 ± 3.59 27.62 ± 4.36 15.24 ± 3.51 7.62 ± 2.59 16.33 ± 3.73 28.57 ± 4.41 29 27.62 ± 4.36
SEVERE/EXTREME
Both sexes
75-79 5.45 ± 1.60 14.85 ± 2.50 2.97 ± 1.19 3.47 ± 1.29 12.11 ± 2.37 4.95 ± 1.53 9 4.46 ± 1.45
80-84 8.61 ± 2.28 17.22 ± 3.07 9.93 ± 2.43 4.64 ± 1.71 21.43 ± 3.47 8.61 ± 2.28 12 7.95 ± 2.20
≥85 21.33 ± 3.34 36.00 ± 3.92 17.33 ± 3.09 16.00 ± 2.99 45.59 ± 4.27 18.00 ± 3.14 30 20.00 ± 3.27
Male
75-79 3.90 ± 2.21 11.69 ± 3.66 3.90 ± 2.21 2.60 ± 1.81 7.46 ± 3.21 3.90 ± 2.21 4 5.19 ± 2.53
80-84 4.55 ± 2.56 13.64 ± 4.22 10.61 ± 3.79 4.55 ± 2.56 14.04 ± 4.60 7.58 ± 3.26 3 4.55 ± 2.56
≥85 22.22 ± 6.20 20.00 ± 5.96 15.56 ± 5.40 11.11 ± 4.68 28.95 ± 7.36 17.78 ± 5.70 7 15.56 ± 5.40
Female
75-79 6.40 ± 2.19 16.80 ± 3.34 2.40 ± 1.37 4.00 ± 1.75 14.63 ± 3.19 5.60 ± 2.06 5 4.00 ± 1.75
80-84 11.76 ± 3.49 20.00 ± 4.34 9.41 ± 3.17 4.71 ± 2.30 26.51 ± 4.84 9.41 ± 3.17 9 10.59 ± 3.34
≥85 20.95 ± 3.97 42.86 ± 4.83 18.10 ± 3.76 18.10 ± 3.76 52.04 ± 5.05 18.10 ± 3.76 23 21.90 ± 4.04
% ± SE: Specific prevalence ± standard error. Life activities domain was non-applicable for 37 individuals. UAC: Understanding and communication; GAP: Getting
along with people; LAC: Life activities; GAR: Getting around; PSO: Participation in society; SCA: Self-care.
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Page 8 of 12with non-computable disability data might have reduced
our prevalence figures (cf., Alzheimer’s type dementia is
one of the major disability determinants in the elderly
[33]). In addition, cognitive function of participants with
non-computable WHO-DAS II was probably slightly infer-
ior than for those with computable scores. Only 25 among
the 41 participants with non-computable WHO-DAS II
had computable MEC scores, and among those, cognitive
function was significantly lower (23.58 ± 10.01 vs. 27.66 ±
6.18; Wilcoxon W, p = .033). These differences are of
moderate-low magnitude and within standard criteria for
computable scores [34].
The highest functioning level was found for GAP with
little variation due to age, suggesting that basic social
skills are preserved until very late in life. PSO on the
other hand, which evaluates more advanced social skills,
showed greater deterioration with age. A similar pattern
was observed for SCA and LAC, as these are related to
basic and instrumental activities of daily living, respec-
tively. Men and women differed in GAR and LAC
domains. Activities in both areas require high cognitive
and motor functioning suggesting that the higher preva-
lence of age-related musculoskeletal and mental disor-
ders (particularly arthritis, osteoporosis and dementia;
see Table S1; online additional file 1) may underlie the
difference in GAR and LAC performance between
women and men.
Multi-dimensional assessment of disability (activities
and participation) based on WHO-DAS II opens up a
more comprehensive view of disability. The performance
of WHO-DAS II as an instrument to inform activities
and participation was satisfactory. However, specific
aspects of the scale need to be developed further. For
instance, the low acceptanceo ft h es e x u a l i t yi t e m ,s u g -
gest that this content (among others that are not applic-
able to all elderly population) needs to be reworded. In
addition, WHO-DAS II does not assess the causes of
disability. Therefore it is not highly useful to develop
strategies to remediate disability. In this respect, ICF
core sets represent a recent expansion of ICF framework
for the assessment of disease-specific factors of disabil-
ity. Core sets are composed of clusters of items that are
distinctively affected under specific health conditions.
Previous studies using the WHO-DAS II have focused
on younger and more specific clinical populations, parti-
cularly psychiatric patients [10,35-37]. Our study illus-
trates the usability of the scale in population-based
studies with elderly participants. The WHO-DAS II
allows assessing concurrently various aspects of disabil-
ity, and could be used as the basis for identifying com-
plex relations between disability, and medical, personal,
social and environmental factors [38].
The development of methodological strategies for the
assessment of disability is highly relevant to clinical epi-
demiology. Until recently, instruments measuring dis-
ability have emphasized clinical profile over behavioral,
social and environmental factors [39]. More specifically,
the validity of classic measures (e.g., Katz Index, Barthel
Index) could be tested against ICF-based approaches to
assessment (e.g., ICF checklist) in order to determine
the relative contribution of personal, environmental and
social factors on individuals’ performance.
Table 4 Prevalence OR and 95% confidence interval of extreme/severe disability cases by age and sex
UAC GAR SCA GAP LAC PSO Summary Index
Men Age (75-70)
80-84 1.18
[0.23, 6.03]
1.19
[0.44, 3.21]
2.93
[0.73, 11.81]
1.79
[0.29, 11.02]
2.02
[0.62, 6.58]
2.02
[0.46, 8.80]
0.87
[0.19, 4.03]
>85 7.05**
[1.82, 27.22]
1.89
[0.69, 5.18]
4.54*
[1.11, 18.57]
4.69
[0.87, 25.24]
5.05*
[1.60, 15.95]
5.33*
[1.34, 21.29]
3.36
[0.93, 12.21]
Women Age (75-70)
80-84 1.95
[0.74, 5.16]
1.24
[0.61, 2.52]
4.22*
[1.09, 16.41]
1.19
[0.31, 4.55]
2.10*
[1.05, 4.23]
1.75
[0.61, 5.02]
2.84
[0.92, 8.80]
>85 3.88*
[1.65, 9.13]
3.71**
[2.02, 6.82]
8.98**
[2.58, 31.29]
5.30*
[1.91, 14.75]
6.33**
[3.34, 11.97]
3.72*
[1.50, 9.24]
6.73**
[2.46, 18.43]
Both Sex (Male)
Female 1.40
[0.75, 2.62]
1.99*
[1.22, 3.24]
0.96
[0.51, 1.83]
1.51
[0.71, 3.25]
2.37**
[1.41, 3.99]
1.18
[0.62, 2.23]
1.48
[0.77, 2.87]
Age (75-70)
80-84 1.67
[0.72, 3.83]
1.24
[0.70, 2.21]
3.60*
[1.36, 9.51]
1.39
[0.48, 4.04]
2.10*
[1.15, 3.82]
1.83
[0.77, 4.29]
1.89
[0.78, 4.62]
>85 4.60**
[2.23, 9.48]
3.12**
[1.86, 5.22]
6.87**
[2.75, 17.19]
5.16
[2.16, 12.36]
6.00**
[3.44, 10.48]
4.16**
[1.94, 8.91]
5.23
[2.39, 11.41]
Reference category in parenthesis. UAC: Understanding and communication; GAP: Getting along with people; LAC: Life activities; GAR: Getting around; PSO:
Participation in society; SCA: Self-care.
*p < .01, **p < .001.
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Page 9 of 12A study of this nature requires ICF-based instruments
that are yet to be developed that would incorporate a
relevant core set of items relevant to the characteristics
of the disability of the population studied. For instance,
this approach has been found effective in assessing the
rehabilitation of patients with stroke [40]. The level of
morbidity found in elderly populations (Table S1; online
additional file 1) suggest the necessity of a generic core
set for elderly people allowing an in-depth assessment
that would facilitate tailoring services for a particular
individual. Our findings are descriptive in nature. There-
fore, no social policy guidelines can be drawn from
them. Nonetheless, our results are consistent with set-
ting the prevention and remediation of severe/extreme
disability in mobility and life activities as a priority for
service planning. Strategic actions would require a more
thorough examination of disability causes, which are
currently the focus of our team.
Conclusions
Although a number of studies assessing disability in var-
ious settings have used the ICF system and the WHO-
DAS II, they have been rarely used as the basis for
screening and assessment in a population-based study
o nt h ep r e v a l e n c eo fd i s a b i lity. This approach may be
superior to more classical means of determining func-
tional status (e.g., ADL, motor and sensory functioning),
which do not allow a multi-faceted appraisal of disabil-
ity. Our study shows that individuals perform differently
in the various areas of disability assessed. Advanced
social skills and instrumental activities of daily living, as
assessed through the PSO and LAC domains of WHO-
DAS II, demonstrated a higher deterioration with age as
opposed to other areas of disability. Women tended to
perform poorer in areas requiring high motor function-
ing, as is the case for the GAR and LAC disability
domains. The level of specificity achieved by using ICF
disability levels and WHO-DAS II may provide essential
information for a more comprehensive development of
services matching the needs of elderly people.
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